SEC 13F Intelligence

Managers / Q1 2021 · view latest →

Kellner Capital, LLC

CIK 0001550188 · PO BOX 1627, NEW YORK, NY, 10150 · 212-350-0262

Reported Value
$276M
Q1 2021
Positions
33
Filings on Record
20
2019–present window
Filed
May 10, 2021
original filing

Summary

Kellner Capital, LLC reported $276M in U.S.-listed holdings across 33 positions for Q1 2021.

Its largest position, Ihs Markit, represents 12.3% of the portfolio.

Compared with Q4 2020, the fund opened 17 new positions and exited 13.

Portfolio Metrics

Turnover
+35.8%
vs prior filed quarter
Top-10 Concentration
+64.2%
share of reported value
Largest Position
+12.3%
Ihs Markit
New / Exited
17 / 13
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $147MQ1 ’19Q2 ’19: $224MQ3 ’19: $142MQ4 ’19: $158MQ4 ’19Q1 ’20: $216MQ2 ’20: $203MQ3 ’20: $185MQ3 ’20Q4 ’20: $190MQ1 ’21: $276MQ2 ’21: $326MQ2 ’21Q3 ’21: $257MQ4 ’21: $219MQ1 ’22: $134MQ1 ’22Q2 ’22: $148MQ3 ’22: $177MQ4 ’22: $86MQ4 ’22Q1 ’23: $72MQ2 ’23: $87MQ3 ’23: $85MQ3 ’23Q4 ’23: $56Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 81.7%Other: 15.3%ADR: 2.7%Unit: 0.3%
  • Common Stock · 81.7% · $225M
  • Other · 15.3% · $42M
  • ADR · 2.7% · $7M
  • Unit · 0.3% · $883,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TCFTCF FINANCIAL CORPNEW+323.0K323.0K+$15M$15M
HMSYHMS HOLDINGS CORPNEW+297.7K297.7K+$11M$11M
FPRXFIVE PRIME THERAPEUTICS INCNEW+226.9K226.9K+$9M$9M
MICHAELS COS INCNEW+277.3K277.3K+$6M$6M
GW PHARMACEUTICALSNEW+25.0K25.0K+$5M$5M
PRSPPERSPECTA INCNEW+168.8K168.8K+$5M$5M
FLIRFLIR SYS INCNEW+78.0K78.0K+$4M$4M
BPFHBOSTON PRIVATE FINL HLDGS INNEW+273.9K273.9K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2021

33 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1IHS MARKIT LTDSHS12.28%$34M349.6K
2WTWWILLIS TOWERS WATSON PLC LTDhistory →SHS8.12%$22M97.7K
3RPREALPAGE INChistory →COM7.41%$20M234.1K
4VARIAN MED SYS INCCOM6.66%$18M103.9K
5CIT GROUP INCCOM NEW5.77%$16M308.4K
6TCFTCF FINANCIAL CORPhistory →COM5.45%$15M323.0K
7WORKSLACK TECHNOLOGIES INChistory →COM CL A5.36%$15M363.3K
8ALXNALEXION PHARMACEUTICALS INChistory →COM5.15%$14M92.8K
9MXIMMAXIM INTEGRATED PRODShistory →COM4.02%$11M121.3K
10HMSYHMS HOLDINGS CORPhistory →COM3.99%$11M297.7K
11XILINX INCCOM3.54%$10M78.7K
12WDRWADDELL & REED FINL INChistory →CL A3.32%$9M365.0K
13FPRXFIVE PRIME THERAPEUTICS INChistory →COM3.10%$9M226.9K
14NAVNAVISTAR INTL CORP NEWhistory →COM2.45%$7M153.2K
15CUBIC CORPCOM2.43%$7M89.8K
16IPHIINPHI CORPhistory →COM2.36%$6M36.4K
17MICHAELS COS INCCOM2.21%$6M277.3K
18CLGXCORELOGIC INChistory →COM2.13%$6M74.2K
19WATFORD HLDGS LTDSHS1.97%$5M156.7K
20GW PHARMACEUTICALSADS1.97%$5M25.0K
21PRSPPERSPECTA INChistory →COM1.78%$5M168.8K
22FLIRFLIR SYS INChistory →COM1.60%$4M78.0K
23BPFHBOSTON PRIVATE FINL HLDGS INhistory →COM1.32%$4M273.9K
24COHERENT INCCOM1.05%$3M11.4K
25GRACE W R & CO DEL NEWCOM0.98%$3M44.9K
26BROOKFIELD PROPERTY PARTRS LUNIT LTD PARTN0.90%$2M139.2K
27SOGOU INCADR REPSTG A0.70%$2M257.0K
28ATATLANTIC POWER CORPCOM NEW0.60%$2M567.7K
29CHANGE HEALTHCARE INCCOM0.48%$1M59.9K
30GNMKGENMARK DIAGNOSTICS INCCOM0.39%$1M44.7K
31EXTENDED STAY AMERICA INCUNIT 99/99/999B0.32%$883,00044.7K
32PLURALSIGHT INCCOM CL A0.15%$400,00017.9K
33FORTERRA INCCOM0.07%$203,0008.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$56M18Feb 7, 202413F-HRchanges · EDGAR ↗
Q3 2023$85M21Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$87M26Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$72M29May 9, 202313F-HRchanges · EDGAR ↗
Q4 2022$86M33Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$177M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$148M33Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$134M31May 12, 202213F-HRchanges · EDGAR ↗
Q4 2021$219M28Feb 10, 202213F-HRchanges · EDGAR ↗
Q3 2021$257M27Nov 10, 202113F-HRchanges · EDGAR ↗
Q2 2021$326M31Aug 9, 202113F-HRchanges · EDGAR ↗
Q1 2021$276M33May 10, 202113F-HRchanges · EDGAR ↗
Q4 2020$190M29Feb 10, 202113F-HRchanges · EDGAR ↗
Q3 2020$185M28Nov 9, 202013F-HRchanges · EDGAR ↗
Q2 2020$203M23Aug 11, 202013F-HRchanges · EDGAR ↗
Q1 2020$216M32May 13, 202013F-HRchanges · EDGAR ↗
Q4 2019$158M31Feb 11, 202013F-HRchanges · EDGAR ↗
Q3 2019$142M27Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$224M33Aug 5, 201913F-HRchanges · EDGAR ↗
Q1 2019$147M27May 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • PRELUDE CAPITAL MANAGEMENT, LLC
  • AXS INVESTMENTS

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.